49 results on '"Jevsevar, David"'
Search Results
2. Examining the Relationship Between Value and Patient Satisfaction With Treatment in Total Joint Arthroplasty
3. What Are the Contraindications for Lateral or Medial Unicondylar Knee Arthroplasty?
4. 2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective
5. The Effect of Intra-articular Hyaluronic Acid Injections and Payer Coverage on Total Knee Arthroplasty Procedures: Evidence From Large US Claims Database
6. Making a Joint Decision Regarding the Timing of Surgery for Elective Arthroplasty Surgery After Being Infected With COVID-19: A Systematic Review
7. Do Physicians Overestimate Radiographic Findings in Patients Undergoing Knee Arthroplasty?
8. Does Hospital Teaching Status Matter? Impact of Hospital Teaching Status on Pattern and Incidence of 90-day Readmissions After Primary Total Hip Arthroplasty
9. Do Patient Engagement Platforms in Total Joint Arthroplasty Improve Patient-Reported Outcomes?
10. Do Patients With Higher Preoperative Functional Outcome Scores Preferentially Seek Direct Anterior Approach Total Hip Arthroplasty?
11. Does Preoperative Opioid Consumption Increase the Risk of Chronic Postoperative Opioid Use After Total Joint Arthroplasty?
12. Perioperative Antibiotic Prophylaxis: Single and 24-Hour Antibiotic Dosages are Equally Effective at Preventing Periprosthetic Joint Infection in Total Joint Arthroplasty
13. Generalized Anxiety Disorder: A Modifiable Risk Factor for Pain Catastrophizing After Total Joint Arthroplasty
14. Metric Selection, Metric Targets, and Risk Adjustment Should be Considered in the Design of Gainsharing Models for Bundled Payment Programs in Total Joint Arthroplasty
15. Does Productivity-Based Physician Compensation Affect Surgical Rates for Elective Arthroplasty Surgery?
16. After the COVID-19 Pandemic: Returning to Normalcy or Returning to a New Normal?
17. Does the Impact of Joint Arthroplasty Extend Beyond the Patient? The Effect of Total Joint Arthroplasty on Patient’s Significant Others
18. A SANE Approach to Outcome Collection? Comparing the Performance of Single- Versus Multiple-Question Patient-Reported Outcome Measures After Total Hip Arthroplasty
19. What Happens to Unused Opioids After Total Joint Arthroplasty? An Evaluation of Unused Postoperative Opioid Disposal Practices
20. Do Medicare’s Patient–Reported Outcome Measures Collection Windows Accurately Reflect Academic Clinical Practice?
21. A One-Question Patient-Reported Outcome Measure Is Comparable to Multiple-Question Measures in Total Knee Arthroplasty Patients
22. Defining and Optimizing Value in Total Joint Arthroplasty From the Patient, Payer, and Provider Perspectives
23. Identifying regional characteristics influencing variation in the utilization of rotator cuff repair in the United States
24. Selecting Residents for Predetermined Factors Identified and Thought to be Important for Work Performance and Satisfaction: A Methodology
25. A comparison of radiographic leg-length and offset discrepancies between 2 intraoperative measurement techniques in anterior total hip arthroplasty
26. Skilled Nursing Facility Placement Process After Total Hip and Total Knee Arthroplasty: Revised Rating System and Opportunities for Intervention
27. Preoperative Patient-Reported Outcomes and Clinical Characteristics as Predictors of 90-Day Cost/Utilization and Complications
28. Are Medicare's Nursing Home Compare Ratings Accurate Predictors of 90-Day Complications, Readmission, and Bundle Cost for Patients Undergoing Primary Total Joint Arthroplasty?
29. Practical Implications of Value-Based Care in the Setting of Ambulatory Surgery Centers
30. Basics of Orthopaedic Commercial and Government Bundling
31. Patient Outcomes After Total Knee Arthroplasty in Patients Older Than 80 Years
32. The Efficacy of Tranexamic Acid in Total Hip Arthroplasty: A Network Meta-analysis
33. Tranexamic Acid Use in Total Joint Arthroplasty: The Clinical Practice Guidelines Endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society
34. The Efficacy of Tranexamic Acid in Total Knee Arthroplasty: A Network Meta-Analysis
35. The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis
36. Laxity Profiles in the Native and Replaced Knee—Application to Robotic-Assisted Gap-Balancing Total Knee Arthroplasty
37. The Cost-Effectiveness of Total Hip Arthroplasty in Patients 80 Years of Age and Older
38. Costs and Risk Factors for Hospital Readmission After Periprosthetic Knee Fractures in the United States
39. Do Aggregate Socioeconomic Status Factors Predict Outcomes for Total Knee Arthroplasty in a Rural Population?
40. Predicting the Incremental Hospital Cost of Adverse Events Among Medicare Beneficiaries in the Comprehensive Joint Replacement Program During Fiscal Year 2014
41. The Incremental Hospital Cost and Length-of-Stay Associated With Treating Adverse Events Among Medicare Beneficiaries Undergoing THA During Fiscal Year 2013
42. The Incremental Hospital Cost and Length-of-Stay Associated With Treating Adverse Events Among Medicare Beneficiaries Undergoing TKA
43. Comment on: The Effect of Intra-articular Hyaluronic Acid Injections and Payer Coverage on Total Knee Arthroplasty Procedures: Evidence From Large U.S. Claims Database
44. Erratum to “2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective” [The Journal of Arthroplasty 38 (2023) 2193-2201]
45. Tobacco Exposure Is Associated With Extremely Low Polyethylene Oxidation in Total Knee Arthroplasty Components
46. AAOS Osteoarthritis Guideline: Transparency and Credibility
47. Response to Letter to the Editor on “The Safety of Tranexamic Acid in Total Joint Arthroplasty: A Direct Meta-Analysis”
48. Wednesday, September 26, 2018 9:00 AM – 10:00 AM Best Papers: 7. Predictors of total hospital resource cost during 1- or 2-level lumbar spinal fusion among Medicare beneficiaries
49. The Incremental Hospital Cost of Complications among Medicare Beneficiaries Undergoing Spinal Fusion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.